By: Benzinga
UPDATE: Jefferies Raises PT on Opko Health on Sufficient Cash Thru 2016
In a report published Wednesday, Jefferies analyst Eun K. Yang reiterated a Buy rating on Opko Health (NYSE: OPK ), and slightly raised the price target from $8.00 to $9.00. In the report, Yang noted, “Estimated current cash of ~$187M including converts net proceeds in 01/13 should be sufficient thru
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here